Published in Adv Virol on August 12, 2010
Serum metabolome and lipidome changes in adult patients with primary dengue infection. PLoS Negl Trop Dis (2013) 0.99
Dengue virus binding and replication by platelets. Blood (2015) 0.98
Highly divergent dengue virus type 1 genotype sets a new distance record. Sci Rep (2016) 0.97
Activation of the innate immune response against DENV in normal non-transformed human fibroblasts. PLoS Negl Trop Dis (2011) 0.92
The importance of hematopoietic progenitor cells in dengue. Ther Adv Hematol (2012) 0.83
Senescence affects endothelial cells susceptibility to dengue virus infection. Int J Med Sci (2014) 0.79
Role of human heterogeneous nuclear ribonucleoprotein C1/C2 in dengue virus replication. Virol J (2015) 0.79
Involvement of Tetraspanin C189 in Cell-to-Cell Spreading of the Dengue Virus in C6/36 Cells. PLoS Negl Trop Dis (2015) 0.76
The Role of Heterotypic DENV-specific CD8(+)T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection. EBioMedicine (2017) 0.75
Analogs of LDL Receptor Ligand Motifs in Dengue Envelope and Capsid Proteins as Potential Codes for Cell Entry. J Viruses (2016) 0.75
Involvement of fatty acid synthase in dengue virus infection. Virol J (2017) 0.75
Flavivirus genome organization, expression, and replication. Annu Rev Microbiol (1990) 14.20
Of mice and not men: differences between mouse and human immunology. J Immunol (2004) 10.61
Dengue. Lancet (2007) 10.54
Research on dengue during World War II. Am J Trop Med Hyg (1952) 8.76
Platelets in atherothrombosis. Nat Med (2002) 5.81
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol (1984) 5.62
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med (2003) 4.69
Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med (1970) 4.41
Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science (2010) 4.22
Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med (2007) 4.20
Antibody-enhanced dengue virus infection in primate leukocytes. Nature (1977) 4.18
A prescription for human immunology. Immunity (2008) 4.09
Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 4.02
In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis (1979) 3.90
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis (2004) 3.81
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A (1988) 3.67
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe (2010) 3.33
Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J Cell Biol (1999) 3.26
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol (2006) 3.07
Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection. J Exp Med (1977) 2.84
CLEC5A is critical for dengue-virus-induced lethal disease. Nature (2008) 2.79
Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA (2008) 2.45
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 2.39
The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest (2005) 2.30
Anucleate platelets generate progeny. Blood (2010) 2.24
Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity (2005) 2.16
Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog (2007) 2.13
Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc Natl Acad Sci U S A (2009) 2.12
The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog (2008) 2.09
Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J Virol (1998) 2.03
Historical review: megakaryopoiesis and thrombopoiesis. Blood (2008) 2.03
Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc (2001) 1.96
Dengue fever in humanized NOD/SCID mice. J Virol (2005) 1.96
Pathology of Thailand haemorrhagic fever: a study of 100 autopsy cases. Ann Trop Med Parasitol (1967) 1.95
Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood (2008) 1.93
The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol (2006) 1.93
Platelet physiology and thrombosis. Thromb Res (2004) 1.90
Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg (2009) 1.87
Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl Trop Dis (2007) 1.86
Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med (1990) 1.82
Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79
Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology (2007) 1.78
Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol (2000) 1.74
Platelets: physiology and biochemistry. Semin Thromb Hemost (2005) 1.72
The platelet release reaction: granules' constituents, secretion and functions. Platelets (2001) 1.71
Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis (2007) 1.71
Association of increased platelet-associated immunoglobulins with thrombocytopenia and the severity of disease in secondary dengue virus infections. Clin Exp Immunol (2004) 1.66
Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 1.66
Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol (2006) 1.61
Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol (2009) 1.57
High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56
STUDIES ON DENGUE VIRUS INFECTION. 1. IMMUNOFLUORESCENT LOCALIZATION OF VIRUS IN MOUSE TISSUE. Arch Pathol (1964) 1.56
Mouse models of dengue virus infection and disease. Antiviral Res (2008) 1.56
Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology (2002) 1.55
Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology (2008) 1.54
Replication of dengue viruses in cultures of peripheral blood leukocytes from dengue-immune rhesus monkeys. J Infect Dis (1976) 1.49
Development of a novel mouse model for dengue virus infection. Virology (1999) 1.47
Evaluation of interferences between dengue vaccine serotypes in a monkey model. Am J Trop Med Hyg (2009) 1.45
Studies on the pathogenesis of dengue infection in monkeys. 3. Sequential distribution of virus in primary and heterologous infections. J Infect Dis (1973) 1.42
Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis (1980) 1.42
Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol Med (2007) 1.41
Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases. Curr Opin Pharmacol (2003) 1.34
Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33
Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection. Am J Trop Med Hyg (1995) 1.31
Detection of dengue virus in platelets isolated from dengue patients. Southeast Asian J Trop Med Public Health (2009) 1.29
Dengue virus-induced hemorrhage in a nonhuman primate model. Blood (2009) 1.29
Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes. Arch Virol (1989) 1.29
Dengue-2 virus infection of human mononuclear cell lines and establishment of persistent infections. Arch Virol (1990) 1.27
Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Res (1991) 1.25
Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg (2001) 1.24
Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology (2008) 1.20
Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood (1991) 1.20
Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol (2007) 1.20
Models of dengue virus infection. Drug Discov Today Dis Models (2006) 1.18
Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg (2003) 1.17
Liver injury and viremia in mice infected with dengue-2 virus. Virology (2005) 1.16
Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol (1992) 1.16
Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci U S A (1986) 1.16
Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol (2005) 1.15
DENGUE FEVER: A THROMBOCYTOPENIC DISEASE? JAMA (1964) 1.15
Histologic, viral, and molecular correlates of dengue fever infection of the liver using highly sensitive immunohistochemistry. Diagn Mol Pathol (2006) 1.14
Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident. J Virol (1999) 1.14
Dengue illness: clinical features and pathogenesis. J Infect Chemother (2007) 1.12
Replication of dengue and junin viruses in cultured rabbit and human endothelial cells. Infect Immun (1978) 1.12
Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res (1990) 1.11
Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin Vaccine Immunol (2007) 1.11
HEMATOLOGIC FINDINGS IN THE 1960 HEMORRHAGIC FEVER EPIDEMIC (DENGUE) IN THAILAND. Am J Trop Med Hyg (1964) 1.11
A re-evaluation of the mechanisms leading to dengue hemorrhagic fever. Ann N Y Acad Sci (2009) 1.10
Viral replication and paracrine effects result in distinct, functional responses of dendritic cells following infection with dengue 2 virus. J Leukoc Biol (2008) 1.09
B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health (1999) 1.09
Depletion of macrophages in mice results in higher dengue virus titers and highlights the role of macrophages for virus control. Eur J Immunol (2009) 1.08
Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines. Vaccine (1999) 1.08
Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol (1988) 1.08
Experimental infection of New World monkeys with dengue and yellow fever viruses. Am J Trop Med Hyg (1958) 1.06
Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection. Exp Biol Med (Maywood) (2008) 1.05
Influenza A H5N1 replication sites in humans. Emerg Infect Dis (2005) 3.21
A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet (2005) 2.31
Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings. J Acquir Immune Defic Syndr (2011) 2.06
Evaluation of an NS1 antigen detection for diagnosis of acute dengue infection in patients with acute febrile illness. Diagn Microbiol Infect Dis (2008) 2.06
Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children. AIDS (2014) 1.91
Avian influenza virus infection of children in Vietnam and Thailand. Pediatr Infect Dis J (2004) 1.83
Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol (2012) 1.74
Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis (2007) 1.72
Cohort profile: the TREAT Asia pediatric HIV observational database. Int J Epidemiol (2010) 1.70
A novel mutation of the CYBB gene resulting in severe form of X-linked chronic granulomatous disease. Asian Pac J Allergy Immunol (2007) 1.41
Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr (2015) 1.33
Detection of dengue virus in platelets isolated from dengue patients. Southeast Asian J Trop Med Public Health (2009) 1.29
Dengue virus-induced hemorrhage in a nonhuman primate model. Blood (2009) 1.29
Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database. J Acquir Immune Defic Syndr (2010) 1.25
Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr (2011) 1.24
Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol (2009) 1.14
Diagnosis disclosure in HIV-infected Thai children. J Med Assoc Thai (2005) 1.13
Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics (2002) 1.11
A re-evaluation of the mechanisms leading to dengue hemorrhagic fever. Ann N Y Acad Sci (2009) 1.10
Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol (2002) 1.07
A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand. Pediatr Infect Dis J (2010) 1.05
Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection. Exp Biol Med (Maywood) (2008) 1.05
Development of a diagnosis disclosure model for perinatally HIV-infected children in Thailand. AIDS Care (2012) 1.04
Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005. Vaccine (2006) 1.03
Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population. PLoS One (2011) 1.02
Infection of bone marrow cells by dengue virus in vivo. Exp Hematol (2011) 1.02
Influenza A viral loads in respiratory samples collected from patients infected with pandemic H1N1, seasonal H1N1 and H3N2 viruses. Virol J (2010) 1.01
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting. AIDS Res Ther (2012) 1.00
Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 0.99
Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children. Int J Infect Dis (2008) 0.99
Quantification of Norwalk virus inocula: Comparison of endpoint titration and real-time reverse transcription-PCR methods. J Med Virol (2010) 0.97
Lessons learnt from studies of the immune characterization of naturally SIV infected sooty mangabeys. Front Biosci (2003) 0.93
Use of recombinant cytokines for optimized induction of antiviral immunity against SIV in the nonhuman primate model of human AIDS. Immunol Res (2004) 0.93
Diagnosis of dengue infection using various diagnostic tests in the early stage of illness. Southeast Asian J Trop Med Public Health (2004) 0.93
Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children. Vaccine (2011) 0.90
Frequency alterations in key innate immune cell components in the peripheral blood of dengue patients detected by FACS analysis. J Innate Immun (2011) 0.89
Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. Clin Infect Dis (2002) 0.89
Effect of antiretroviral therapy in human immunodeficiency virus-infected children. J Med Assoc Thai (2005) 0.88
Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter. Virology (2002) 0.88
Bacteremia and antimicrobial susceptibilities in HIV-infected patients at Siriraj Hospital. Southeast Asian J Trop Med Public Health (2005) 0.88
Intestinal microsporidiosis in HIV-infected children with diarrhea. Southeast Asian J Trop Med Public Health (2002) 0.87
Role of microparticles in dengue virus infection and its impact on medical intervention strategies. Yale J Biol Med (2012) 0.87
Differences in the constitutive and SIV infection induced expression of Siglecs by hematopoietic cells from non-human primates. Cell Immunol (2008) 0.87
First case report of brucellosis in a child in Thailand. Southeast Asian J Trop Med Public Health (2014) 0.86
Effect of perinatal short-course zidovudine on the clinical and virological manifestations of HIV-1 subtype E infection in infants. J Clin Virol (2002) 0.86
Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy. Int J Infect Dis (2013) 0.86
Challenges for the formulation of a universal vaccine against dengue. Exp Biol Med (Maywood) (2013) 0.86
Can non-human primates serve as models for investigating dengue disease pathogenesis? Front Microbiol (2013) 0.86
Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy. Int J Pharm (2012) 0.85
The role of disease stage, plasma viral load and regulatory T cells (Tregs) on autoantibody production in SIV-infected non-human primates. J Autoimmun (2007) 0.85
Hospital-based epidemiologic survey of malignancies in children infected with human immunodeficiency virus in Thailand. Pediatr Infect Dis J (2005) 0.85
Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol (2010) 0.84
Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr Infect Dis J (2014) 0.84
Dengue virus infection in late pregnancy and transmission to the infants. Pediatr Infect Dis J (2008) 0.84
Mortality from septic shock in a dengue infected patient: a case report. Southeast Asian J Trop Med Public Health (2013) 0.84
Implication of pneumococcal conjugate vaccines to public health: Thailand perspective. J Med Assoc Thai (2010) 0.84
Successful treatment of disseminated BCG infection in a SCID patient with granulocyte colony stimulating factor. Asian Pac J Allergy Immunol (2008) 0.83
Recurrent Campylobacter lari bacteremia in X-linked agammaglobulinemia: a case report and review. Asian Pac J Allergy Immunol (2006) 0.83
Unravelling the neuropathogenesis of Japanese encephalitis. Trans R Soc Trop Med Hyg (2007) 0.83
Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing. Pediatr Infect Dis J (2015) 0.83
The importance of hematopoietic progenitor cells in dengue. Ther Adv Hematol (2012) 0.83
Cell death gene expression profile: role of RIPK2 in dengue virus-mediated apoptosis. Virus Res (2010) 0.83
Final Height and Associated Factors in Perinatally HIV-infected Asian Adolescents. Pediatr Infect Dis J (2016) 0.83
Indinavir/ritonavir remains an important component of HAART for the treatment of HIV/AIDS, particularly in resource-limited settings. Expert Opin Drug Metab Toxicol (2007) 0.82
Evaluation of a practical method to assess antiretroviral adherence in HIV-infected Thai children. Southeast Asian J Trop Med Public Health (2007) 0.82
Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerg Infect Dis (2015) 0.82
A description of antimicrobial susceptibility of Streptococcus pneumoniae-Siriraj Hospital, Thailand: 2008. J Med Assoc Thai (2010) 0.82
Echocardiography and carotid intima-media thickness among asymptomatic HIV-infected adolescents in Thailand. AIDS (2014) 0.82
Role of CD61+ cells in thrombocytopenia of dengue patients. Int J Hematol (2012) 0.82
Health-related Quality of Life of Thai children with HIV infection: a comparison of the Thai Quality of Life in Children (ThQLC) with the Pediatric Quality of Life Inventory™ version 4.0 (PedsQL™ 4.0) Generic Core Scales. Qual Life Res (2010) 0.82
Outcomes of a Comprehensive Youth Program for HIV-infected Adolescents in Thailand. J Assoc Nurses AIDS Care (2015) 0.82
Dyslipidemia and lipodystrophy in HIV-infected Thai children on highly active antiretroviral therapy (HAART). J Med Assoc Thai (2005) 0.81
Weight as predictors of clinical progression and treatment failure: results from the TREAT Asia Pediatric HIV Observational Database. J Acquir Immune Defic Syndr (2014) 0.81
Immunogenicity and safety study of a new DTaP-IPV-Hep B-PRP-T combined vaccine compared to a licensed DTaP-IPV-Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants. Int J Infect Dis (2011) 0.81
Herpes simplex virus type 1 ICP0 localizes in the stromal layer of infected rabbit corneas and resides predominantly in the cytoplasm and/or perinuclear region of rabbit keratocytes. J Gen Virol (2006) 0.81
Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012. Hum Vaccin Immunother (2014) 0.81
Carbapenem-resistant Acinetobacter baumannii bacteremia in neonates. Pediatr Infect Dis J (2013) 0.81
Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome. J Biomed Sci (2013) 0.80
Immunogenicity of a human rotavirus vaccine (RIX4414) after storage at 37 °C for seven days. Hum Vaccin (2011) 0.80